Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • chapterNo Access

    Multipotent Progenitor Cells: A New Era In Stem Cell-Mediated Gene Therapy?

    Over the last decade, a number of studies have provided evidence of the existence of stem cells with pluripotency properties either in fresh bone marrow or following in vitro culture. Numerous groups have isolated non-hematopoietic cell populations from bone marrow, umbilical cord blood, amniotic fluid or fetal tissue via in vitro culture, which possess some molecular and biological properties comparable to embryonic stem cells. Due to their differentiation capacity into cells with features of the three germ layers, they are a novel cellular source for tissue regeneration. Because such stem cells of greater potency can be expanded for prolonged periods ex vivo without evidence of senescence and can be easily genetically manipulated, they can also be considered good candidates for gene therapy approaches.